There's a new blood test to screen for colorectal cancer, but a new study found it's not as effective as a colonoscopy or ...

Let’s start with the cheapest, the yearly FIT, or fecal immunochemical test, which looks for fecal blood that might be caused ...

A new study analysed the efficacy of blood tests versus colonoscopies and stool tests in identifying early-stage CRC. Read ...

Colorectal cancer screening is important to prevent CRC-related death. New blood and stool tests show promising results.

Screening tests are designed to find cancers or precancers before they become lethal. But are prostate, lung, and breast ...

Thermo Fisher Scientific has signed an agreement with German molecular genetics company Mainz Biomed, the developer of ...

Fecal immunochemical tests for post-polypectomy colorectal cancer surveillance may reduce the need for colonoscopy and improve screening adherence. Stool-based post-polypectomy surveillance strategies ...

Based on a validated model of colorectal cancer screening, cell-free DNA blood tests may deliver net benefit when screening ...

"We've got a screening test that works. It works as well, if not better, than breast and colorectal cancer screening in terms ...

The maker of the Cologuard colon cancer screening test lowered its full-year outlook. CEO Kevin Conroy said the firm's quarterly execution and forecast don't reflect its full potential.

Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed has announced a collaboration with Thermo Fisher Scientific to develop a next-generation colorectal cancer screening test. This ...

A majority of people who are eligible for lung cancer screening responded that they hadn't heard of the test or hadn't discussed it with a clinician.